Review: taking Tekturna and Exforge together


Summary

Drug interactions are reported among people who take Tekturna and Exforge together. This review analyzes the effectiveness and drug interactions between Tekturna and Exforge. It is created by eHealthMe based on reports of 310 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Tekturna

Tekturna has active ingredients of aliskiren hemifumarate. It is often used in high blood pressure. (latest outcomes from Tekturna 4,101 users)

Exforge

Exforge has active ingredients of amlodipine besylate; valsartan. It is often used in high blood pressure. (latest outcomes from Exforge 7,784 users)

On Sep, 26, 2016

310 people who take Tekturna, Exforge are studied.


Number of reports submitted per year:

Tekturna and Exforge drug interactions.

Drug effectiveness over time:

Tekturna:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Exforge:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Tekturna:
  • female: 100.0% - (1 of 1 people)
  • male: 50.0% - (1 of 2 people)
Exforge:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 2 people)

Drug effectiveness by age:

Tekturna:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 100.0% - (2 of 2 people)
  • 60+: 0.0% - (0 of 0 people)
Exforge:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • pruritus
  • erythema
  • hallucination
  • hyperkalaemia
  • leukocytoclastic vasculitis
  • oedema peripheral
  • rash
  • arthralgia
  • blood pressure increased
  • cholelithiasis
1 - 6 months:
  • blood creatinine increased
  • oedema peripheral
  • blood urea increased
  • blood pressure increased
  • syncope
  • arrhythmia
  • blood potassium decreased
  • cardiac failure
  • glomerular filtration rate decreased
  • hyponatraemia
6 - 12 months:
  • cardiac failure
  • bile duct cancer
  • blood creatinine increased
  • blood potassium decreased
  • blood urea increased
  • glomerular filtration rate decreased
  • oedema peripheral
  • renal impairment
  • blood pressure decreased
  • blood pressure fluctuation
1 - 2 years:
  • alcohol abuse
  • blood pressure increased
  • nephrolithiasis
  • angina pectoris
  • blood pressure diastolic decreased
  • blood triglycerides increased
  • bronchospasm
  • cardiac flutter
  • dyspnoea
  • fatigue
2 - 5 years:
  • histiocytosis
  • blood pressure decreased
  • cardiac failure
  • dyspnoea
  • fall
  • fatigue
  • hyperuricaemia
  • local swelling
  • myocardial infarction
  • nephropathy
not specified:
  • blood pressure increased
  • dyspnoea
  • oedema peripheral
  • hypertension
  • blood glucose increased
  • arthralgia
  • blood creatinine increased
  • dizziness
  • hypertensive crisis
  • hypotension

Most common drug interactions by gender *:

female:
  • blood pressure increased
  • oedema peripheral
  • dyspnoea
  • hypotension
  • pain in extremity
  • fall
  • hypertensive crisis
  • cardiac failure
  • arthralgia
  • blood pressure inadequately controlled
male:
  • blood creatinine increased
  • blood pressure increased
  • hypertension
  • blood glucose increased
  • oedema peripheral
  • dyspnoea
  • renal impairment
  • pruritus
  • dizziness
  • arthralgia

Most common drug interactions by age *:

10-19:
  • cerumen impaction
  • cough
  • dysphonia
  • fall
  • hypoacusis
  • infarction
  • injury
  • pregnancy
  • tinnitus
20-29:
  • blood pressure increased
  • deep vein thrombosis
  • gait disturbance
  • gestational diabetes
  • injury
  • maternal exposure during pregnancy
  • normal newborn
  • pain in extremity
  • premature labour
30-39:
  • proteinuria
  • urine albumin/creatinine ratio increased
  • alcohol abuse
  • blood pressure increased
  • drug ineffective
  • hypotension
  • oedema peripheral
  • paraesthesia
40-49:
  • blood pressure increased
  • cardiac flutter
  • hypertension
  • angina pectoris
  • angiopathy
  • blood corticotrophin abnormal
  • blood cortisol increased
  • blood pressure decreased
  • bronchospasm
  • cerebrovascular accident
50-59:
  • blood creatinine increased
  • oedema peripheral
  • renal impairment
  • blood pressure increased
  • blood potassium decreased
  • blood urea increased
  • cardiac failure
  • glomerular filtration rate decreased
  • nephrolithiasis
  • arrhythmia
60+:
  • dyspnoea
  • blood pressure increased
  • oedema peripheral
  • fall
  • hypotension
  • blood glucose increased
  • hypertensive crisis
  • arthralgia
  • blood creatinine increased
  • blood urea increased

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Tekturna and Exforge?

Can you answer these questions?

More questions for: Tekturna, Exforge

You may be interested in these reviews

More reviews for: Tekturna, Exforge

On eHealthMe, Tekturna (aliskiren hemifumarate) is often used to treat high blood pressure. Exforge (amlodipine besylate; valsartan) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.